Ganesh Benzoplast disclosed on August 19, 2026, that Ravi Pilani intends to acquire 28,56,810 equity shares of the company through a gift transfer from promoters Rishi Pilani and Poonam Pilani. The proposed transaction falls under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which exempts off-market transfers between promoters and their immediate relatives from making an open offer.

The acquisition will be completed on or before August 27, 2026. As this is an inter-se transfer among immediate relatives, there is no change in the aggregate holding of the promoter and promoter group. The total stake held by the promoter group remains unchanged before and after the transaction.

Transaction Details

The shares are being transferred without consideration. The breakdown of the proposed acquisition is as follows:

Ravi Pilani, who is not currently a promoter of the company but is an immediate relative (brother) of Chairman and Managing Director Rishi Pilani, will hold 3.97% of the total paid-up share capital post-transaction. Prior to this transfer, his holding was zero.

Regulatory Compliance

The company filed the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ravi Pilani submitted the requisite disclosure under Regulation 10(5) of the SEBI (SAST) Regulations, 2011, confirming compliance with all conditions for exemption. The acquirer declared that all applicable requirements in Chapter V of the Takeover Regulations have been met.

Ganesh Benzoplast Limited reported a consolidated net profit of ₹175.82 million for the quarter ended June 30, 2026 (Q1FY27), a 3% decline from ₹181.33 million in the corresponding period of FY26. Consolidated revenue from operations surged 23% year-on-year to ₹1,174.95 million, up from ₹956.18 million in Q1FY26. However, EBITDA declined to ₹270 million from ₹291 million in the same period last year, with the EBITDA margin contracting sharply to 22.98% from 30.44% year-on-year, highlighting significant margin pressure despite robust top-line growth. The results were approved by the Board of Directors on August 11, 2026, and reviewed by statutory auditors Mittal & Associates under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Standalone net profit fell 5% to ₹134.40 million from ₹140.91 million in Q1FY26, while standalone revenue rose 24% to ₹703.39 million. Earnings per share (basic) stood at ₹2.44 for consolidated results and ₹1.87 for standalone results, compared to ₹2.52 and ₹2.06 respectively in the prior year quarter.

Key Financial Highlights

The following table summarises the key consolidated and standalone financial metrics for the quarter:

Segment Performance

The Chemical Division emerged as the primary growth engine in Q1FY27. Revenue from this segment increased by 27% year-on-year to ₹626.93 million, contributing significantly to the overall top-line expansion. The segment's profit before tax and interest but after depreciation rose sharply to ₹81.53 million from ₹71.95 million in Q1FY26. In contrast, the Logistics, Supply Chain & Infrastructure (LST) Division saw revenue grow more modestly by 18% to ₹548.03 million, with segment profits declining to ₹179.03 million from ₹210.66 million in the same period last year.

Note: LST Division includes EPC, Wharfage Income & Rail Logistic.

Margin Pressure and Cost Dynamics

The EBITDA margin compression from 30.44% to 22.98% underscores a key divergence in Q1FY27 results — the decoupling of revenue growth from profitability at the consolidated level. While revenue expanded by 23%, the sharp decline in EBITDA margin points to rising operational costs outpacing top-line gains. Specifically, 'Other expenses' in the consolidated statement rose to ₹464.24 million from ₹345.52 million in Q1FY26, a 34% increase that outpaced revenue growth. The standalone results show a similar pattern, with other expenses jumping to ₹329.31 million from ₹250.73 million, indicating sustained pressure on operating margins despite top-line gains. Finance costs in the consolidated statement stood at ₹20.07 million compared to ₹23.28 million in the prior year, reflecting a slight decrease.

Legal Developments

The auditor's report included an emphasis of matter regarding a First Information Report (FIR) and complaint registered with the Economic Office Wing (EOW) against the parent company, its directors, and key managerial personnel in July 2024. The allegations relate to loans and borrowings allegedly undertaken in FY23-24 by the then director of GBL Chemical Ltd and the CEO through an unauthorized bank account with State Bank of India. Ganesh Benzoplast Limited has filed a petition to quash the FIR, which is currently pending before the High Court of Delhi. The company stated that it had reported the event to exchanges and authorities immediately upon occurrence.